Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 68 Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous Tumor. | Clin Nucl Med | 2023 | 36854307 | PubTator, text mining | PubMed |
| A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer. | Pharmaceutics | 2023 | 36839802 | PubTator, text mining | PubMed |
| Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs. | Medicina (Kaunas) | 2023 | 36837574 | PubTator, text mining | PubMed |
| The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-Analysis. | J Pers Med | 2023 | 36836538 | PubTator, text mining | PubMed |
| Delving into Acromegaly. | J Clin Med | 2023 | 36836189 | PubTator, text mining | PubMed |
| Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies. | Int J Mol Sci | 2023 | 36835022 | PubTator, text mining | PubMed |
| Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT. | Diagnostics (Basel) | 2023 | 36832093 | PubTator, text mining | PubMed |
| The Role of PET/CT in Breast Cancer. | Diagnostics (Basel) | 2023 | 36832085 | PubTator, text mining | PubMed |
| Modulating T Cell Responses by Targeting CD3. | Cancers (Basel) | 2023 | 36831533 | PubTator, text mining | PubMed |
| An Insight on Functioning Pancreatic Neuroendocrine Neoplasms. | Biomedicines | 2023 | 36830839 | PubTator, text mining | PubMed |
| Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma. | Jpn J Radiol | 2023 | 36826759 | PubTator, text mining | PubMed |
| Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN). | Curr Oncol Rep | 2023 | 36826704 | PubTator, text mining | PubMed |
| Strategies for clinical dose optimization of T cell-engaging therapies in oncology. | MAbs | 2023 | 36823042 | PubTator, text mining | PubMed |
| Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. | Nat Commun | 2023 | 36810324 | PubTator, text mining | PubMed |
| Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells. | Nucl Med Commun | 2023 | 36804512 | PubTator, text mining | PubMed |
| Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme. | Front Oncol | 2023 | 36793596 | PubTator, text mining | PubMed |
| What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022? | BMC Cancer | 2023 | 36782152 | PubTator, text mining | PubMed |
| Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues. | Cancer Cell Int | 2023 | 36774501 | PubTator, text mining | PubMed |
| miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly. | Int J Mol Sci | 2023 | 36769196 | PubTator, text mining | PubMed |
| Tumors of the Nose and Paranasal Sinuses: Promoting Factors and Molecular Mechanisms-A Systematic Review. | Int J Mol Sci | 2023 | 36768990 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=35